ASCO has issued a policy statement calling for the use of human papillomavirus (HPV) vaccines to be rapidly expanded to protect thousands of young people in the United States and millions worldwide from life-threatening cancers. The statement is published in the Journal of Clinical Oncology and outlines current barriers to HPV vaccination and recommendations to promote the uptake of these vaccines, which have the potential to save millions of lives.
This study found that ninety-seven percent of all evaluated classical Hodgkin lymphomas had concordant alterations of the PD-L1 and PD-L2 loci. In addition, the analysis identified an association between PD-L1 protein expression and relative genetic alterations in this series. Furthermore, progression-free survival was significantly shorter for patients with 9p24.1 amplification.
Visit the redesigned iPlanner to browse abstract titles, search sessions, and build your personalized schedule. Improvements to the tool include a simplified program and enhanced search. The iPlanner website automatically syncs with the iPlanner mobile app for seamless planning.
Whether you are new to oncology practice or an experienced Advanced Practitioner wanting to supplement your on-the-job training, these new certificate programs give you the added knowledge and confidence to contribute effectively to the care team and provide high-quality patient care.
The Centers for Medicare & Medicaid Services (CMS) released a proposal to reduce the Average Sales Price reimbursement rate based on primary care service areas, sparking concerns over its singular focus on drug costs. ASCO responded strongly in opposition, and will keep pressure on CMS to withdraw the proposal and focus on real reform. Individuals may voice opposition through ASCO’s ACT Network.